Emerging Infectious Diseases (Apr 2023)

Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022

  • Zeno Bisoffi,
  • Nicoletta De Santis,
  • Chiara Piubelli,
  • Michela Deiana,
  • Francesca Perandin,
  • Pietro Girardi,
  • Luca Heller,
  • Natalia Alba,
  • Carlo Pomari,
  • Massimo Guerriero

DOI
https://doi.org/10.3201/eid2904.221268
Journal volume & issue
Vol. 29, no. 4
pp. 822 – 825

Abstract

Read online

We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boosters to elderly and frail persons seems justified.

Keywords